Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss) from operations	$ 400,443	$ (4,200,573)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	11,834	15,004
Stock-based compensation expense		11,255
Changes in assets and liabilities:
Insurance receivable		200,000
Prepaid expenses and other current assets	436,961	681,637
Reduction of right of-use assets	185,176	180,306
Accounts payable	226,745	(494,708)
Other assets		9,133
Decrease in lease liabilities	(196,002)	(185,593)
Accrued expenses and other current liabilities	(51,265)	(1,049,005)
Net cash provided by (used in) operating activities	1,013,892	(4,832,464)
Cash flows from investing activities:
Purchases of equipment and furnishings		(766)
Net cash used in investing activities		(766)
Cash flows from financing activities:
Purchase of Investment Option	(250,000)
Preferred stock dividend	(68,809)	(561,381)
Net cash used in financing activities	(318,809)	(561,381)
Net increase (decrease) in cash and cash equivalents	695,083	(5,394,611)
Cash and cash equivalents at beginning of year	1,374,992	6,769,603
Cash and cash equivalents at end of year	2,070,075	1,374,992
Non-cash investing and financing activities
Issuance of common stock upon conversion of preferred shares	$ 1,343,684	$ 2,679,016